- Home
- SYRE vs TPG Comparison
SYRE vs TPG Comparison
Compare SYRE & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYRE | TPG |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | 1900 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.0B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | TPG |
|---|---|---|
| Price | $86.72 | $41.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | ★ $85.08 | $61.20 |
| AVG Volume (30 Days) | 892.9K | ★ 2.1M |
| Earning Date | 05-08-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.79 |
| P/E Ratio | ★ N/A | $106.82 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.49 | $36.95 |
| 52 Week High | $88.03 | $70.38 |
Technical Indicators
Market Signals| Indicator | SYRE | TPG |
|---|---|---|
| Relative Strength Index (RSI) | 67.73 | 46.89 |
| Support Level | $66.78 | $41.43 |
| Resistance Level | N/A | $42.17 |
| Average True Range (ATR) | 4.83 | 1.86 |
| MACD | 1.12 | 0.10 |
| Stochastic Oscillator | 82.70 | 35.93 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About TPG TPG Inc.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms, namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company invests across a broadly diversified set of strategies, including private equity, impact, credit, real estate, market solutions, innovation, and inclusion.